Pharmaceutical Analysis & Statistics in Japan, December 2012 (p30)

Talk to Louis

+1 718 618 4302

Search inside this page

All regions

You might be interested in: therapeutics, drug, cancer, more »

871-900 of about 1 700 reports

Purchase Reports From Reputable Market Research Publishers

OTC Medications - Japan   (2012)

OTC Medications - Japan (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

OTC Medications in Japan by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...

  • Industries : Over-the-counter Drug
  • Countries : Japan
Vitamins & Minerals - Japan   (2012)

Vitamins & Minerals - Japan (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

Vitamins & Minerals in Japan by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and minerals. ...

  • Industries : Vitamin and Supplement
  • Countries : Japan
Merger and Acquisition Terms and Agreements

Merger and Acquisition Terms and Agreements

  • $ 2 995
  • Company report
  • December 2012
  • by Currentpartnering

Summary The Merger and Acquisition Terms and Agreements report provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Pharmaceutical
  • Countries : Japan
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...

  • Industries : Pharmaceutical
  • Countries : World, United States, United Kingdom, Netherlands, Europe, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...

  • Industries : Pharmaceutical
  • Countries : World, United States, United Kingdom, Netherlands, Europe, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides

  • $ 1 495
  • Industry report
  • December 2012
  • by MarketLine Industry Guides

Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis

PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Japan
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, ?PharmaPoint: Rheumatoid Arthritis - Japan Drug ...

  • Industries : Pathology
  • Countries : Japan
Hisamitsu Pharmaceutical Co., Inc.: Company Capsule

Hisamitsu Pharmaceutical Co., Inc.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Hisamitsu Pharmaceutical Co., Inc. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, ...

  • Industries : Drug and Medication
  • Countries : Japan
Taiko Pharmaceutical Co.,Ltd.: Company Capsule

Taiko Pharmaceutical Co.,Ltd.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Taiko Pharmaceutical Co.,Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, majo ...

  • Industries : Pharmaceutical
  • Countries : Japan
Mikasa Seiyaku Co., Ltd.: Company Capsule

Mikasa Seiyaku Co., Ltd.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Mikasa Seiyaku Co., Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products ...

  • Industries : Prescription Drug
  • Countries : Japan
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • November 2012
  • by Global Data

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022 Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such ...

  • Industries : Drug and Medication
  • Countries : Japan, India, China, United States, United Kingdom, Spain, Italy, Germany, France, World, Europe, Asia
Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Japan, Australia, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Czech Republic, United States, Spain, Italy, France, Germany, Japan, World, Europe, United Kingdom
Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, India
Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, India, China, United States, Europe, United Kingdom
Humira (Rheumatoid Arthritis) Forecast and Market Analysis

Humira (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Humira (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Humira (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Remicade (Rheumatoid Arthritis) Forecast and Market Analysis

Remicade (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Remicade (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Remicade (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, India, China, United States, Europe, United Kingdom
Simponi (Rheumatoid Arthritis) Forecast and Market Analysis

Simponi (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Simponi (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Simponi (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Japan, Australia, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis

Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Company report
  • November 2012
  • by Global Data

Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Orencia (Rheumatoid Arthritis) Forecast and Market Analysis

Orencia (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Company report
  • November 2012
  • by Global Data

Orencia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Orencia (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom, India
Actemra (Rheumatoid Arthritis) Forecast and Market Analysis

Actemra (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Company report
  • November 2012
  • by Global Data

Actemra (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Actemra (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, India, China, World, United States, Australia, Europe, United Kingdom
Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis

Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Company report
  • November 2012
  • by Global Data

Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : United States, Spain, Italy, France, Germany, Japan, India, World, Australia, Europe, United Kingdom
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Agrippal (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, Germany, India, China, World, France, Japan, United States, United Kingdom, Europe
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Spain, Italy, France, Germany, Japan
ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis

ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?ASP7374 (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Japan, South Korea, World, Asia, China
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Injuries Industry in Japan

  • Underreporting of Trayc Injuries Involving Children in Japan
  • July 2014
    4 pages
  • Injuries  

  • Japan  

    United States  

View report >

31 Companies

Read our Company Profiles

Icon Group

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.